Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
27 Julho 2017 - 10:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 000-50867
Syneron Medical Ltd.
(Exact name of registrant as specified in its charter)
Industrial Zone, Yokneam Illit 20692, P.O.B. 550, Israel
+972-73-244-2200
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, par value NIS 0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒
|
|
Rule 12g-4(a)(2)
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
☒
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
Rule 15d-6
|
☐
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Syneron Medical Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date:
|
|
July 27, 2017
|
|
By:
|
|
/s/ Michael Johnson
|
|
|
|
|
Name:
|
|
Michael Johnson
|
|
|
|
|
Title:
|
|
Chief Financial Officer
|
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Syneron Medical Ltd. - Ordinary Shares da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Syneron Medical Ltd.